Pre-dose levels of thrombospondin-1, fibronectin, periostin, and IL-6 showed a trend to elevation in the CKD cohort for all the factors examined except SPARC, which may be consistent with the disease state promoting overproduction of these proteins (Supplementary Table S3). Here, SPARC is linked to chronic kidney disease.